The binuclear cyclopalladated complex CP2 is targeting ubiquinol-cytochrome c reductase (complex III) of Leishmania amazonensis

Leishmaniasis is a neglected disease that remains with a limited number of drugs available for chemotherapy and has an increased drug resistance that affects treatment outcomes. Metal-based drugs such as cyclopalladated complex [Pd(dmba)(μ-N3)]2 (CP2), a Leishmania topoisomerase IB inhibitor involve...

Full description

Saved in:
Bibliographic Details
Main Authors: Angela Maria Arenas Velásquez, Irwin Alexander Patino Linares, Lawrence D. Gaspers, Paula J. Bartlett, Jecika M. Velasques, Adelino V.G. Netto, Andrew P. Thomas, Marcia A.S. Graminha
Format: Article
Language:English
Published: Elsevier 2025-04-01
Series:International Journal for Parasitology: Drugs and Drug Resistance
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2211320724000551
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items